Atlas Trials

A Trial of Nimotuzumab and Pinkiller Efficacy and Pain in Advanced Head and Neck Squamous Cell Carcinoma

Clinical trial NCT06879691 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06879691
Sponsor
Biotech Pharmaceutical Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Head and Neck Cancer
Start date
2021-05-15
Primary completion
2025-04-14
Enrollment
171

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.